Wendy Perrow
Plus aucun poste en cours
Historique de carrière de Wendy Perrow
Anciens postes connus de Wendy Perrow
Sociétés | Poste | Début | Fin |
---|---|---|---|
FEMASYS INC. | Directeur/Membre du Conseil | 19/01/2022 | 08/11/2023 |
Independent Dir/Board Member | 19/01/2022 | 08/11/2023 | |
AsclepiX Therapeutics LLC
AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD. | Directeur Général | 01/01/2016 | 01/01/2020 |
Alba Therapeutics Corp.
Alba Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba's technology platform is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, Crohn's disease, asthma/COPD and acute lung injury. As a development stage company Alba maximizes value creation by leveraging its human capital, partnerships and technology. Since the Company's formation in 2004, the company has entered human clinical trials with its lead product, received Fast Track designation from the FDA (in Celiac Disease), successfully completed three Phase I clinical trials and completed its first Phase II study. Along with $30m raised in its Series A financing, equity and non-equity capital, such as SBIR and ATP grants and venture debt, are being used to develop products, enhance its powerful IP position and build the Company's infrastructure and core competencies | Directeur Général | 07/11/2013 | 01/01/2016 |
Corporate Officer/Principal | 31/03/2009 | 15/01/2010 | |
President | 01/01/2008 | 01/01/2016 | |
Sales & Marketing | 15/01/2010 | 07/11/2013 | |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Sales & Marketing | 01/01/2004 | 31/12/2007 |
MERCK & CO., INC. | Corporate Officer/Principal | 01/01/1989 | - |
INOTIV, INC. | Directeur/Membre du Conseil | 10/12/2015 | - |
Independent Dir/Board Member | 10/12/2015 | - | |
A Dinner of Hope, Inc. | Directeur/Membre du Conseil | - | - |
Formation de Wendy Perrow
Duke University | Undergraduate Degree |
Eastern Illinois University | Undergraduate Degree |
The Fuqua School of Business | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 11 |
Opérationnelle
Director/Board Member | 3 |
Sales & Marketing | 2 |
Undergraduate Degree | 2 |
Sectorielle
Health Technology | 4 |
Consumer Services | 4 |
Commercial Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
INOTIV, INC. | Commercial Services |
FEMASYS INC. | Electronic Technology |
Entreprise privées | 4 |
---|---|
Alba Therapeutics Corp.
Alba Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba's technology platform is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, Crohn's disease, asthma/COPD and acute lung injury. As a development stage company Alba maximizes value creation by leveraging its human capital, partnerships and technology. Since the Company's formation in 2004, the company has entered human clinical trials with its lead product, received Fast Track designation from the FDA (in Celiac Disease), successfully completed three Phase I clinical trials and completed its first Phase II study. Along with $30m raised in its Series A financing, equity and non-equity capital, such as SBIR and ATP grants and venture debt, are being used to develop products, enhance its powerful IP position and build the Company's infrastructure and core competencies | Health Technology |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Health Technology |
A Dinner of Hope, Inc. | |
AsclepiX Therapeutics LLC
AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD. | Commercial Services |
- Bourse
- Insiders
- Wendy Perrow
- Expérience